Argus Research downgrades Leidos Holdings (NYSE:LDOS) from Buy to Hold.
ERYTECH Pharma Shares Down 34.7% After Co. Announced It Will Stop Further Plans To Pursue BLA Seeking Approval For Graspa In Hypersensitive ALL
ERYTECH to stop further plans to pursue a BLA submission seeking an approval for Graspa® in hypersensitive ALL
Evaluation of strategic partnering options ongoing
Cambridge, MA (U.S.) and Lyon (France),